-
-
-
-
-
-
-
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
-
-
-
-
-
-
-
Jaguar Health expands crofelemer compassionate use to EU infant
-
-
-
-
-
-
-
Jaguar Health files for full FDA approval of dog diarrhea drug
-
-
-
-
-
-
-
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
-
-
-
-
-
-
-
Jaguar Health Compliant with Nasdaq Bid Price Rule
-
-
-
-
-
-
-
Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
-
-
-
-
-
-
-
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
-
460,607 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

